Bulgaria Renewable Energy Policy Handbook 2026

1.1 Catalyst
1.2 Related reports
1.3 Upcoming reports

2.1 Disease background
2.2 Risk factors and comorbidities
2.3 Global and historical trends
2.4 7MM forecast methodology
2.4.1 Sources
2.4.2 Forecast assumptions and methods
2.4.3 Forecast assumptions and methods: active prevalent cases of epilepsy
2.4.4 Forecast assumptions and methods: active diagnosed prevalent cases of epilepsy by seizure type
2.4.5 Forecast assumptions and methods: diagnosed prevalent cases of epilepsy by type - Dravet syndrome and Lennox-Gastaut syndrome
2.5 Epidemiological forecast for epilepsy (2025-35)
2.5.1 Active diagnosed prevalent cases of epilepsy
2.5.2 Age-specific active diagnosed prevalent cases of epilepsy
2.5.3 Sex-specific active diagnosed prevalent cases of epilepsy
2.5.4 Active diagnosed prevalent cases of epilepsy by seizure type
2.5.5 Diagnosed prevalent cases of Dravet syndrome
2.5.6 Diagnosed prevalent cases of Lennox-Gastaut syndrome
2.6 Discussion
2.6.1 Epidemiological forecast insight
2.6.2 Limitations of the analysis
2.6.3 Strengths of the analysis

3.1 Bibliography
3.2 About the Authors
3.2.1 Epidemiologist
3.2.2 Reviewers
3.2.3 Vice President of Disease Intelligence and Epidemiology
3.2.4 Global Head of Pharma Research, Analysis, and Competitive Intelligence

• About the Analyst
• Contact the Publisher

Table 1: Summary of newly added data types
Table 2: Summary of updated data types
Table 3: Risk factors and comorbidities for epilepsy
Figure 1: 7MM, active diagnosed prevalent cases of epilepsy, both sexes, N, =18 Years, 2025 and 2035
Figure 2: 7MM, diagnosed prevalent cases of DS, both sexes, N, =18 Years, 2025 and 2035
Figure 3: 7MM, diagnosed prevalent cases of LGS, both sexes, N, =18 Years, 2025 and 2035
Figure 4: 7MM, active diagnosed prevalence of epilepsy, men and women, %, =18 Years, 2015-35
Figure 5: 7MM, sources used and not used to forecast the active diagnosed prevalent cases of epilepsy
Figure 6: 7MM, sources used to forecast the active diagnosed prevalent cases of epilepsy by seizure type
Figure 7: 7MM, sources used to forecast the diagnosed prevalent cases of DS
Figure 8: 7MM, sources used to forecast the diagnosed prevalent cases of LGS
Figure 9: 7MM, active diagnosed prevalent cases of epilepsy, N, both sexes, =18 Years, 2025
Figure 10: 7MM, active diagnosed prevalent cases of epilepsy by age, N, both sexes, 2025
Figure 11: 7MM, active diagnosed prevalent cases of epilepsy by sex, N, =18 Years, 2025
Figure 12: 7MM, active diagnosed prevalent cases of epilepsy by seizure type, N, both sexes, =18 Years, 2025
Figure 13: 7MM, diagnosed prevalent cases of DS, N, both sexes, =18 Years, 2025
Figure 14: 7MM, diagnosed prevalent cases of LGS, N, both sexes, =18 Years, 2025